Novacyt S.A.
NCYT.L · LSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 103.8% | -46.7% | -10.3% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 32.6% | 66.4% | 17.5% | 32.3% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -45.1% | -44.2% | -184.9% | -136.9% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -31.8% | -64.8% | -258.5% | -171.5% |
| EPS Diluted | -0.092 | -0.05 | -0.34 | -0.25 |
| % Growth | -83% | 85.3% | -36% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |